JP2014502624A5 - - Google Patents

Download PDF

Info

Publication number
JP2014502624A5
JP2014502624A5 JP2013548820A JP2013548820A JP2014502624A5 JP 2014502624 A5 JP2014502624 A5 JP 2014502624A5 JP 2013548820 A JP2013548820 A JP 2013548820A JP 2013548820 A JP2013548820 A JP 2013548820A JP 2014502624 A5 JP2014502624 A5 JP 2014502624A5
Authority
JP
Japan
Prior art keywords
liquid medium
drug
suspension
pharmaceutically acceptable
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013548820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014502624A (ja
JP5934719B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050336 external-priority patent/WO2012095439A1/en
Publication of JP2014502624A publication Critical patent/JP2014502624A/ja
Publication of JP2014502624A5 publication Critical patent/JP2014502624A5/ja
Application granted granted Critical
Publication of JP5934719B2 publication Critical patent/JP5934719B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013548820A 2011-01-12 2012-01-11 薬物懸濁液の調製におけるクロスフロー濾過を用いた液体培地交換の使用 Active JP5934719B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161431942P 2011-01-12 2011-01-12
US61/431,942 2011-01-12
PCT/EP2012/050336 WO2012095439A1 (en) 2011-01-12 2012-01-11 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions

Publications (3)

Publication Number Publication Date
JP2014502624A JP2014502624A (ja) 2014-02-03
JP2014502624A5 true JP2014502624A5 (enExample) 2015-02-26
JP5934719B2 JP5934719B2 (ja) 2016-06-15

Family

ID=45478323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013548820A Active JP5934719B2 (ja) 2011-01-12 2012-01-11 薬物懸濁液の調製におけるクロスフロー濾過を用いた液体培地交換の使用

Country Status (10)

Country Link
US (1) US9066864B2 (enExample)
EP (1) EP2663287A1 (enExample)
JP (1) JP5934719B2 (enExample)
CN (1) CN103347499B (enExample)
AU (1) AU2012206621B2 (enExample)
BR (1) BR112013016851B1 (enExample)
CA (1) CA2823972C (enExample)
MX (1) MX346749B (enExample)
SG (2) SG10201807631SA (enExample)
WO (1) WO2012095439A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6478959B2 (ja) * 2016-09-07 2019-03-06 株式会社富士薬品 粒子含有組成物を製造するためのシステム及び方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4790912B2 (ja) 1999-05-12 2011-10-12 メタボリックス,インコーポレイテッド ポリヒドロキシアルカノエートを精製するための方法
EP1225968B1 (en) 1999-09-17 2006-04-05 Alfa Laval Nakskov A/S A method and an apparatus for continuous cross-flow diafiltration
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
WO2003055469A1 (en) * 2001-12-21 2003-07-10 Celator Technologies Inc. Improved polymer-lipid delivery vehicles
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle
PL208585B1 (pl) * 2002-10-25 2011-05-31 Intervet Int Bv Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca cefquinom, sposób jej wytwarzania i zastosowanie cefquinomu
ITMI20022674A1 (it) 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
CN102811743B (zh) * 2009-12-11 2015-11-25 佰恩德治疗股份有限公司 冻干治疗颗粒的稳定制剂

Similar Documents

Publication Publication Date Title
Mehta et al. Magnetic adsorbents for the treatment of water/wastewater—a review
Tabernero et al. Supercritical fluids for pharmaceutical particle engineering: Methods, basic fundamentals and modelling
EA201590059A1 (ru) Вирусная фильтрация сред клеточных культур
AR091538A1 (es) Purificacion de particulas tipo virus
CN103415520B8 (zh) 吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用
JP2012518034A5 (enExample)
MX363327B (es) Materiales zeoliticos de tipo cha y metodos para su preparacion usando compuestos de cicloalquilamonio.
WO2014008400A3 (en) Fill-finish process for peptide solutions
JP2010539337A5 (enExample)
PH12016500814A1 (en) Heteroaryl butanoic acid derivatives
PH12015502449A1 (en) Particle size reduction of an antimuscarinic compound
MY166378A (en) Zeoltic materials and methods for their preparation using alkenyltrialkylammonium compounds
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
JP2017507778A5 (ja) 高効率な逆浸透膜フィルタ
JP2014520848A5 (enExample)
WO2009007992A3 (en) Pharmaceutical composition produced by microprecipitation
BR112013029147A2 (pt) meio de filtração de líquidos, sistema de filtração para filtrar as partículas dos líquidos e processo para a produção de um meio de filtração de líquidos
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
WO2013024494A3 (en) Amorphous mixture of lopinavir and ritonavir co-precipitated on copovidone
HK1220120A1 (zh) 制造注射蛋白质微粒悬浮液的方法
JP2014505663A5 (enExample)
JP2017517574A5 (enExample)
SG10201807631SA (en) Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
RU2012133403A (ru) Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в конжаковой камеди в бутиловом спирте
RU2015149454A (ru) Способ получения нанокапсул антибиотиков тетрациклинового ряда в конжаковой камеди